Insulin detemir Subcutaneous and Lanoxin Pediatric Intravenous
Determining the interaction of Insulin detemir Subcutaneous and Lanoxin Pediatric Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: digoxin
Brand name: Lanoxin, Digitek, Digox, Lanoxicaps, Cardoxin
Synonyms: Lanoxin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir Subcutaneous-Lanoxin Tablets
- Insulin detemir Subcutaneous-Lanreotide
- Insulin detemir Subcutaneous-Lanreotide Acetate
- Insulin detemir Subcutaneous-Lanreotide Subcutaneous
- Insulin detemir Subcutaneous-Lansoprazole
- Insulin detemir Subcutaneous-Lansoprazole Delayed-Release Capsules
- Lanoxin Pediatric Intravenous-Insulin glargine
- Lanoxin Pediatric Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Lanoxin Pediatric Intravenous-Insulin Glargine (U-100) Vials
- Lanoxin Pediatric Intravenous-Insulin Glargine (U-300) Pens
- Lanoxin Pediatric Intravenous-Insulin glargine and lixisenatide
- Lanoxin Pediatric Intravenous-Insulin glargine and lixisenatide Subcutaneous